$2.55
0.5527.50%
Last update: Nov 10, 4:03 PM
Comments
Loading...
Nuo Therapeutics Analyst Ratings and Price Targets | OTC:AURX | Benzinga
Nuo Therapeutics Inc has a consensus price target of $3 based on the ratings of 1 analysts. The high is $3 issued by Roth Capital on December 16, 2025. The low is $3 issued by Roth Capital on December 16, 2025. The 1 most-recent analyst ratings were released by Roth Capital on December 16, 2025, respectively. With an average price target of $3 between Roth Capital, there's an implied 17.65% upside for Nuo Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth Capital
1calculated from analyst ratings
Analyst Ratings for Nuo Therapeutics
FAQ
What is the target price for Nuo Therapeutics (AURX) stock?
The latest price target for Nuo Therapeutics (OTCQB:AURX) was reported by Roth Capital on December 16, 2025. The analyst firm set a price target for $3.00 expecting AURX to rise to within 12 months (a possible 17.65% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nuo Therapeutics (AURX)?
The latest analyst rating for Nuo Therapeutics (OTCQB:AURX) was provided by Roth Capital, and Nuo Therapeutics initiated their buy rating.
When was the last upgrade for Nuo Therapeutics (AURX)?
There is no last upgrade for Nuo Therapeutics
When was the last downgrade for Nuo Therapeutics (AURX)?
There is no last downgrade for Nuo Therapeutics.
When is the next analyst rating going to be posted or updated for Nuo Therapeutics (AURX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuo Therapeutics was filed on December 16, 2025 so you should expect the next rating to be made available sometime around December 16, 2026.
Is the Analyst Rating Nuo Therapeutics (AURX) correct?
While ratings are subjective and will change, the latest Nuo Therapeutics (AURX) rating was a initiated with a price target of $0.00 to $3.00. The current price Nuo Therapeutics (AURX) is trading at is $2.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
